Literature DB >> 1370382

Interleukin-11 enhances human megakaryocytopoiesis in vitro.

M Teramura1, S Kobayashi, S Hoshino, K Oshimi, H Mizoguchi.   

Abstract

We investigated the effect of recombinant human interleukin-11 (rhIL-11) on human megakaryocytopoiesis. Nonadherent and T-cell-depleted human bone marrow (BM) mononuclear cells were cultured in a serum-free agar culture system. rhIL-11 alone did not stimulate the growth of human megakaryocyte colonies. However, when rhIL-11 was combined with optimal or suboptimal doses of rhIL-3, the number and size of the megakaryocyte colonies increased. The same results were obtained when highly purified BM CD34-positive cells were used as target cells. Next, we investigated the effect of rhIL-11 on the ploidy of megakaryocytes. The ploidy distribution of individual cells in megakaryocyte colonies obtained by rhIL-11 in combination with rhIL-3 was significantly shifted towards higher values. Furthermore, when highly purified CD41-positive BM cells were cultured in the presence of rhIL-11, the ploidy distribution was shifted towards higher values. This effect was not suppressed by anti-IL-6 antibody. These results suggest that rhIL-11 acts directly as a megakaryocyte potentiator and may play a role in regulating human megakaryocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370382

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Pharmacokinetics of [125I]-recombinant human interleukin-11: 1. Absorption, distribution and excretion after subcutaneous administration to male rats.

Authors:  T Uchida; K Aoyama; K Mori; T Usui; T Watanabe; Y Takariki; N Asahara; M Hirose; T Kimura; M Tateishi; S Higuchi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jul-Sep       Impact factor: 2.441

2.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

Review 3.  Recent developments in ex vivo platelet production.

Authors:  Retno Wahyu Nurhayati; Yoshihiro Ojima; Masahito Taya
Journal:  Cytotechnology       Date:  2016-03-22       Impact factor: 2.058

4.  Multiple and highly divergent IL-11 genes in teleost fish.

Authors:  Mark O Huising; Corine P Kruiswijk; Jessica E van Schijndel; Huub F J Savelkoul; Gert Flik; B M Lidy Verburg-van Kemenade
Journal:  Immunogenetics       Date:  2005-07-08       Impact factor: 2.846

5.  Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11.

Authors:  Jingya Zhang; Yueting Zhang; Dipankar J Dutta; Azeb T Argaw; Virginie Bonnamain; Jeremy Seto; David A Braun; Andleeb Zameer; Fernand Hayot; Carolina B Lòpez; Cedric S Raine; Gareth R John
Journal:  J Immunol       Date:  2011-06-27       Impact factor: 5.422

6.  Effective prevention of thrombocytopenia in mice using adenovirus-mediated transfer of HST-1 (FGF-4) gene.

Authors:  H Konishi; T Ochiya; H Sakamoto; M Tsukamoto; I Saito; T Muto; T Sugimura; M Terada
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

Review 7.  Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents.

Authors:  R L Basser; C G Begley
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

8.  Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.

Authors:  Alexandre Calon; Elisa Espinet; Sergio Palomo-Ponce; Daniele V F Tauriello; Mar Iglesias; María Virtudes Céspedes; Marta Sevillano; Cristina Nadal; Peter Jung; Xiang H-F Zhang; Daniel Byrom; Antoni Riera; David Rossell; Ramón Mangues; Joan Massagué; Elena Sancho; Eduard Batlle
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

9.  Interleukin-11: a new cytokine critical for osteoclast development.

Authors:  G Girasole; G Passeri; R L Jilka; S C Manolagas
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  Acid-catalyzed peptide bond hydrolysis of recombinant human interleukin 11.

Authors:  R A Kenley; N W Warne
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.